Analysis of Predictive Value of Laboratory Indexes for Malignant Lymphoma Patients with Bone Marrow Involvement.
10.19746/j.cnki.issn.1009-2137.2021.03.018
- Author:
Tai-Gang ZHU
1
;
Yue-Hong LI
2
;
Fei-Hu ZHANG
2
;
Jun HAN
2
;
Xiao-Lei DU
2
;
Xiao-Jiao ZHANG
2
;
Bing WEI
2
Author Information
1. Department of Hematology, Wanbei Coal and Electricity Group General Hospital, Suzhou 234011, Anhui Province, China,E-mail: ztgwzy@163.com.
2. Department of Hematology, Wanbei Coal and Electricity Group General Hospital, Suzhou 234011, Anhui Province, China.
- Publication Type:Journal Article
- MeSH:
Bone Marrow;
Humans;
Laboratories;
Lymphoma;
Prognosis;
Retrospective Studies
- From:
Journal of Experimental Hematology
2021;29(3):763-771
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the influence of bone marrow involvement (BMI) in patients with malignant lymphoma (ML) on laboratory indexes, and evaluate the laboratory markers that can be used to predict/diagnose BMI.
METHODS:The clinical characteristics and laboratory indexes of 137 ML patients were analyzed retrospectively, from which the indexes of BMI in ML patients was studied. The logistic regression analysis and receiver operating curve (ROC) were used to evaluate independent risk factors and predictors of BMI diagnosis in ML patients.
RESULTS:Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, β
CONCLUSION:PLT and sIL2R show good diagnostic value for ML patients with BMI.
